AGTR1 and Hypertension: Despite the absence of statistical significance, pre-transplant use of ACEi or ARBs was more amongst AT1R-Abs positive patients who developed FSGS, which is possibly reflecting the higher prevalence of pre-transplant hypertension in that population.